ホーム › 肝臓がん（肝細胞がん） › アリゾナ州
アリゾナ州における肝臓がん（肝細胞がん）の臨床試験
アリゾナ州内の拠点で、肝臓がん（肝細胞がん）に関する17件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
A Phase 1 Study of the Safety and Tolerability of CTX-10726
- Mayo Clinic Arizona, Phoenix
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07419841Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #67, Phoenix
- Exelixis Clinical Site #1, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
- Research Facility, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06726161GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- University of Arizona Cancer Center, Tucson
被験者募集中早期第1相
18歳〜99歳 · 全性別 · 2026/09/18更新 · NCT07627191A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- City of Hope Phoenix Cancer Center, Goodyear
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT06427941Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, Phoenix
- Research Site, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06921785A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- HonorHealth Research Institute, Scottsdale
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/08/19更新 · NCT07636785FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Phoenix
- Honor Health, Scottsdale
- Arizona Cancer Center at University of Arizona, Tucson
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
- Mayo Clinic in Arizona, Scottsdale
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05168163A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Phoenix
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/17更新 · NCT06600321Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Southern Arizona VA Health Care System, Tucson, AZ, Tucson
被験者募集中
18歳〜75歳 · 全性別 · 2026/06/17更新 · NCT05486572Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Arizona, Phoenix
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/12更新 · NCT06349642Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Scottsdale Medical Imaging, LLC, Scottsdale
被験者募集中第4相
18歳〜64歳 · 全性別 · 2026/01/22更新 · NCT04373564A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Mayo Clinic in Arizona, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/25更新 · NCT05824975Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- HonorHealth Research Institute, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2024/02/08更新 · NCT04282044ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。